评估老年人对适当多药物的坚持:干预试验的结果措施的选择
Hanadi A Al Shaker1,2, Heather E Barry2, Carmel M Hughes2
1Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan.
Journal of the American Geriatrics Society
|January 29, 2026
概括
这项研究选择了四种关键的结果测量仪器 (OMI) 来评估老年人多药效应. 这些工具将有助于评估改善药物管理和生活质量的干预措施.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 结果测量工具 (OMI) 对于评估医疗保健干预的有效性和质量至关重要.
- 采用标准化的OMI仍然是临床研究和实践中的重大挑战.
- 老年人的多药性需要可靠的工具来衡量坚持和相关结果.
研究的目的:
- 为核心结果集 (COS) 选择合适的OMI,重点关注老年人遵守适当的多药.
- 为这个特定的患者群体建立对最相关和可行的OMI的共识.
主要方法:
- 文献审查确定了COS结果的潜在OMI及其可行性.
- 两轮Delphi问卷调查对专家 (学者,医疗保健工作者,编辑,方法学家) 进行了管理,以缩小OMI的选择范围.
- 进行了共识会议和公开采访,以根据预定义的协议门 (≥80%关键,≤20%不重要) 完成OMI选择.
主要成果:
- 21个OMI最初由39-42名专家进行了评估.
- 选择了四个OMI:遵守补充和药物量表 (ARMS),多病症治疗负担问卷 (MTBQ),与药物相关的负担生活质量问卷 (MRB-QoL),以及对不良后果的测量.
- 对测量主观药物坚持,治疗负担,HRQoL和不良事件达成共识;然而,在OMI的成本效益或医疗利用方面没有达成协议.
结论:
- 这项研究成功地确定并选择了四个关键的OMI用于COS,以评估老年人对多药的坚持.
- 选择的OMI解决了关键方面,包括药物坚持,治疗负担,HRQoL和不良事件.
- 需要进一步的研究来确定合适的OMI,以便在此背景下确定成本效益和医疗保健利用结果.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


